Drug Shortage Report for MIDAZOLAM INJECTION
Report ID | 112478 |
Drug Identification Number | 02242905 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | Midazolam injectable |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 5MG |
Dosage form(s) | LIQUID |
Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
Packaging size | 5 mg/mL, fioles DUM de 1 mL |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-05-01 |
Estimated end date | 2020-06-01 |
Actual end date | 2020-05-11 |
Shortage status | Resolved |
Updated date | 2020-06-18 |
Company comments | On 110% Allocation |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2020-06-18 | French | Compare |
v4 | 2020-06-18 | English | Compare |
v3 | 2020-05-02 | English | Compare |
v2 | 2020-04-20 | French | Compare |
v1 | 2020-04-20 | English | Compare |
Showing 1 to 5 of 5